2016 - 2019 IMPROVED GENE TRANSDUCTION WITH RECOMBINANT AAV FOLLOWING IMMUNE TOLERANCE.
2014 - 2017 Development of rAAV-mediated brain transduction with transient ultrasound-mediated modulation of the blood-brain interface in adult common marmoset toward modeling epilepsy
2014 - 2017 Investigation of immune tolerance induction method for gene therapy of muscular dystrophy
2010 - 2015 AAV vector-mediated cell and gene therapy for neuronal diseases
Yuko Nitahara-Kasahara, Mutsuki Kuraoka, Yuki Oda, Hiromi Hayashita-Kinoh, Shin'ichi Takeda, Takashi Okada. Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy. Stem cell research & therapy. 2021. 12. 1. 105-105
Yuko Nitahara-Kasahara, Mutsuki Kuraoka, Posadas Herrera Guillermo, Hiromi Hayashita-Kinoh, Yasunobu Maruoka, Aki Nakamura-Takahasi, Koichi Kimura, Shin'ichi Takeda, Takashi Okada. Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy. Stem cell research & therapy. 2021. 12. 1. 78-78
Kazuhisa Takahashi, Tsutomu Igarashi, Koichi Miyake, Maika Kobayashi, Yuko Katakai, Hiromi Hayashita-Kinoh, Chiaki Fujimoto, Shuhei Kameya, Hiroshi Takahashi, Takashi Okada. Amount of Green Fluorescent Protein in the Anterior Chamber after Intravitreal Injection of Triple-Mutated Self-Complementary AAV2 Vectors is Not Affected by Previous Vitrectomy Surgery. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2021. 88. 2. 103-108
Hiromi Hayashita-Kinoh, Posadas Herrera-Guillermo, Yuko Nitahara-Kasahara, Mutsuki Kuraoka, Shin'ichi Takeda, Takashi Okada. Development of Administration Protocols for Reduction of the Necessary Dose of rAAV for Treatment. MOLECULAR THERAPY. 2022. 30. 4. 494-494
Hiromi Hayashita-Kinoh, Yuko Nitahara-Kasahara, Mutsuki Kuraoka, Shin'ichi Takeda, Takashi Okada. Improved Transduction of DMD Dog with rAAV-Microdystrophin via Multipotent Mesenchymal Cell Pretreatment. MOLECULAR THERAPY. 2021. 29. 4. 287-288
Hiromi Hayashita-Kinoh, Yuko Nitahara-Kasahara, Mutsuki Kuraoka, Kazuhiro Takao, Tsutomu Igarashi, Shin'ichi Takeda, Takashi Okada. Development of Administration Protocols for Reduction of the Necessary Dose of rAAV for Treatment. MOLECULAR THERAPY. 2020. 28. 4. 327-327